Συγγραφείς:
Papageorgiou, S.G.
Thomopoulos, T.P.
Spathis, A.
Bouchla, A.
Glezou, I.
Stavroulaki, G.
Gkontopoulos, K.
Bazani, E.
Foukas, P.G.
Pappa, V.
Λέξεις-κλειδιά:
lactate dehydrogenase; rituximab, adult; bone marrow; cancer prognosis; cancer staging; diffuse large B cell lymphoma; disease predisposition; event free survival; female; human; International Prognostic Index; lactate dehydrogenase blood level; Letter; major clinical study; male; middle aged; monoclonal immunoglobulinemia; priority journal; complication; diffuse large B cell lymphoma; disease management; health survey; incidence; outcome assessment; paraproteinemia; prognosis, Disease Management; Female; Humans; Incidence; Lymphoma, Large B-Cell, Diffuse; Male; Paraproteinemias; Patient Outcome Assessment; Prognosis; Public Health Surveillance; Rituximab
